Original Article

Improving Postoperative Efficiency: An Algorithm for Expedited Void Trials After Urogynecologic Surgery

Authors: A. Rebecca Meekins, MD, Nazema Y. Siddiqui, MD, MHS, Cindy L. Amundsen, MD, Maragatha Kuchibhatla, PhD, Alexis A. Dieter, MD

Abstract

Objectives: To evaluate the relation between voided volume and void trial “success” to create an algorithm that minimizes the need for postvoid residual volume (PVR) assessment in backfill-assisted void trials.

Methods: This article is an ancillary analysis of deidentified data from a randomized trial evaluating prophylactic antibiotics after urogynecologic surgery. Void trials were routinely performed after surgery; voided volumes, PVR, and void trial outcomes were collected. The void trial regimen was as follows: the bladder was backfilled with 300 mL of normal saline or until the patient reported the urgency to void, the catheter was removed, and the participant was prompted to void immediately. PVR volume was measured either by sonographic bladder scan or catheterization. Voided volumes were categorized in 25-mL increments from 50 to 225 mL. For each voided volume range, the PVR and void trial outcome data were incorporated to calculate sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in terms of ability of voided volume alone to predict a passing void trial result. An algorithm was created using the voided volumes that optimize PPV and NPV.

Results: The study population included 255 participants. Voided volumes <100 mL and ≥200 mL were identified as optimal thresholds to predict failure and passage of backfill-assisted void trials, respectively. When patients voided <100 mL, 3% passed their void trial (NPV odds ratio 96.7, 95% confidence interval 88.6–99.5). When patients voided ≥200 mL, 97% passed (PPV odds ratio 97.4, 95% confidence interval 93.5–99.3).

Conclusions: We propose an algorithm for void trials after urogynecologic surgery. After backfilling the bladder if voided volume is ≥200 mL, the void trial is successful and no PVR is needed; if voided volume is between 100 and 199 mL, the void trial is indeterminate and PVR is recommended; and if voided volume is <100 mL, the void trial is unsuccessful and catheterization is needed. Applying this algorithm to our study population would have eliminated the need for PVR in 85% of patients. Calculated PPVs and NPVs depend on the prevalence of voiding dysfunction in the population being studied, and therefore may be unique to our institution.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Oliphant SS, Wang L, Bunker CH, et al. Trends in stress urinary incontinence inpatient procedures in the United States, 1979-2004. Am J Obstet Gynecol 2009;200:521.e1-e6.
 
2. Dieter AA, Wilkins MF, Wu JM. Epidemiological trends and future care needs for pelvic floor disorders. Curr Opin Obstet Gynecol 2015;27:380-384.
 
3. Kobak WH, Walters MD, Piedmonte MR. Determinants of voiding after three types of incontinence surgery: a multivariable analysis. Obstet Gynecol 2001;97:86-91.
 
4. Sze EH, Miklos JR, Karram MM. Voiding after Burch colposuspension and effects of concomitant pelvic surgery: correlation with preoperative voiding mechanism. Obstet Gynecol 1996;88(4 Pt 1):564-567.
 
5. Brady CM, Ahmed I, Drumm J, et al. A prospective evaluation of the efficiency of early postoperative bladder emptying after the Stamey procedure or pubovaginal sling for stress urinary incontinence. J Urol 2001;165:1601-1604.
 
6. Bidmead J, Cardozo L. Retropubic urethropexy (Burch colposuspension). Int Urogynecol J Pelvic Floor Dysfunct 2001;12:262-265.
 
7. Smith RN, Cardozo L. Early voiding difficulty after colposuspension. Br J Urol 1997;80:911-914.
 
8. Norton PA, Nager CW, Chai TC, et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology 2013;82:1038-1041.
 
9. Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2015;7:CD006375.
 
10. Natale F, La Penna C, Saltari M, et al. Voiding dysfunction after anti-incontinence surgery. Minerva Ginecol 2009;61:167-172.
 
11. Vierhout ME. Prolonged catheterization after vaginal prolapse surgery. Acta Obstet Gynecol Scand 1998;77:997-999.
 
12. Hakvoort RA, Thijs SD, Bouwmeester FW, et al. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG 2011;118:1055-1060.
 
13. Foster RT, Sr Borawski KM, South MM, et al. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007;197:627.e1-e4.
 
14. Wohlrab KJ, Erekson EA, Korbly NB, et al. The association between regional anesthesia and acute postoperative urinary retention in women undergoing outpatient midurethral sling procedures. Am J Obstet Gynecol 2009;200:571.e1-571.e5.
 
15. Partoll LM. Efficacy of tension-free vaginal tape with other pelvic reconstructive surgery. Am J Obstet Gynecol 2002;186:1292-1298.
 
16. Geller EJ. Prevention and management of postoperative urinary retention after urogynecologic surgery. Int J Womens Health 2014;6:829-838.
 
17. Walter PJ, Dieter AA, Siddiqui NY, et al. Perioperative anticholinergic medications and risk of catheterization after urogynecologic surgery. Female Pelvic Med Reconstr Surg 2014;20:163-167.
 
18. Book NM, Novi B, Novi JM, et al. Postoperative voiding dysfunction following posterior colporrhaphy. Female Pelvic Med Reconstr Surg 2012;18:32-34.
 
19. Hakvoort RA, Burger MP, Emanuel MH, et al. A nationwide survey to measure practice variation of catheterisation management in patients undergoing vaginal prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:813-818.
 
20. Pulvino JQ, Duecy EE, Buchsbaum GM, et al. Comparison of 2 techniques to predict voiding efficiency after inpatient urogynecologic surgery. J Urol 2010;184:1408-1412.
 
21. Sweeney DD, Leng WW. Treatment of postoperative voiding dysfunction following incontinence surgery. Curr Urol Rep 2005;6:365-370.
 
22. Delorme E, Droupy S, de Tayrac R, et al. Transobturator tape (Uratape): a new minimally-invasive procedure to treat female urinary incontinence. Eur Urol 2004;45:203-207.
 
23. Ingber MS, Vasavada SP, Moore CK, et al. Force of stream after sling therapy: safety and efficacy of rapid discharge care pathway based on subjective patient report. J Urol 2011;185:993-997.
 
24. Tunitsky-Bitton E, Murphy A, Barber MD, et al. Assessment of voiding after sling: a randomized trial of 2 methods of postoperative catheter management after midurethral sling surgery for stress urinary incontinence in women. Am J Obstet Gynecol 2015;212:597.e1-597.e9.
 
25. Dieter AA, Amundsen CL, Edenfield AL, et al. Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial. Obstet Gynecol 2014;123:96-103.
 
26. Al-Badr A, Ross S, Soroka D, et al. Voiding patterns and urodynamics after a tension-free vaginal tape procedure. J Obstet Gynaecol Can 2003;25:725-730.
 
27. Mutone N, Brizendine E, Hale D. Factors that influence voiding function after the tension-free vaginal tape procedure for stress urinary incontinence. Am J Obstet Gynecol 2003;188:1477-1483.
 
28. Carpenter JS, Heit M, Rand KL. Development and psychometric properties of a measure of catheter burden with bladder drainage after pelvic reconstructive surgery. Neurourol Urodyn 2017;36:1140-1146.